10x Genomics (TXG) Reports Q1 Loss, Tops Revenue Estimates

10x Genomics (TXG) came out with a quarterly loss of $0.36 per share versus the Zacks Consensus Estimate of a loss of$ 0.45. This compares to loss of $0.50 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 20%. A quarter ago, it was expected that this life science technology company would post a loss of$ 0.32 per share when it actually produced a loss of $0.40, delivering a surprise of -25%.Over the last four quarters, the compa ...